- Home
- AM vs QGEN Comparison
AM vs QGEN Comparison
Compare AM & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AM | QGEN |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 10.2B |
| IPO Year | 2017 | 1998 |
Fundamental Metrics
Financial Performance| Metric | AM | QGEN |
|---|---|---|
| Price | $22.66 | $40.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $22.50 | ★ $51.30 |
| AVG Volume (30 Days) | ★ 2.4M | 1.8M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | 3.96% | ★ 5.87% |
| EPS Growth | ★ 3.61 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $1,188,426,000.00 | N/A |
| Revenue This Year | $4.92 | $8.18 |
| Revenue Next Year | $6.74 | $5.66 |
| P/E Ratio | $26.44 | ★ $24.01 |
| Revenue Growth | ★ 7.43 | N/A |
| 52 Week Low | $15.08 | $38.58 |
| 52 Week High | $23.84 | $57.82 |
Technical Indicators
Market Signals| Indicator | AM | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 41.52 |
| Support Level | $22.45 | N/A |
| Resistance Level | $23.84 | $48.60 |
| Average True Range (ATR) | 0.54 | 0.88 |
| MACD | -0.17 | 0.33 |
| Stochastic Oscillator | 32.40 | 80.83 |
Price Performance
Historical ComparisonAbout AM Antero Midstream Corporation
Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin, located in West Virginia and Ohio. The company has two operating segments: the Gathering and Processing segment, which includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio, and the Water Handling segment, which includes two independent systems that deliver water from sources including the Ohio River, local reservoirs, and several regional waterways. The company derives a majority of its revenue from the Gathering and Processing segment.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).